Effects of antithrombin III (ATIII) treatment (high dose) in severe pre-eclampsia and HELLP syndrome with alterations of coagulation inhibitors and inflammatory markers: a preliminary report

Documenti analoghi

• Modifications of coagulation imbalance during antithrombin treatment in preeclamptic patients: our experience
  di: Buscemi, C, et al.
  Pubblicazione: (2008)
• Coagulation and Fibrinolytic Systems in Pre-eclampsia and Eclampsia
  di: Bonnar, John, et al.
  Pubblicazione: (1971)
• Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.
  di: Molho-Sabatier, P, et al.
  Pubblicazione: (1989)
• Assessment of Coagulation and Fibrinolysis in Pre-eclampsia
  di: Wood, S. M., et al.
  Pubblicazione: (1974)
• Bell's palsy in pregnancy: underlying HELLP syndrome or pre-eclampsia?
  di: Pourrat, O, et al.
  Pubblicazione: (2017)